Emerging Wellness Science

What "emerging" means in health research, why new, popular or heavily marketed is not the same as effective, safe or approved, and how to place any idea on the path from…

The plain-language evidence and status labels used across Specialty Topics, what each one means, and why cell and animal findings or lab markers are never treated as pro…

A plain guide to judging health headlines built on cell studies, animal studies, small trials and preprints, with questions to ask and examples of why early results ofte…

How a finding in the laboratory becomes, or fails to become, something used in care, what translational research means, and where wellness claims often skip steps.

Why "it acts on a pathway" is not the same as "it helps people", with real trial examples where a sound-sounding mechanism or a good lab marker did not match the outcome.

What cell studies, animal studies and human trials can and cannot show, why in vitro and in vivo results often fail to carry over to people, and how to read the wording …

What Phase 1, 2, 3 and 4 clinical trials are for, how many people take part, what each phase can and cannot show, and why a trial phase is not a verdict on whether a tre…

What feasibility, safety and efficacy studies each can and cannot show, why a small early study cannot prove a treatment is safe or works, and how to read the labels.

Efficacy is how well something works in a controlled trial; effectiveness is how well it works in everyday care. Learn why the two can differ and what real-world evidenc…

A registered trial is a promise to study something, not proof it worked. Learn how registration, results reporting and journal publication differ, and where results go m…

A preprint is a public draft not yet certified by peer review. Learn what changes between preprint and journal, what peer review does and does not guarantee, and how to …

Replication means getting consistent results in a new study; reproducibility means re-running the same data and code. Learn what large replication projects found and wha…

A statistically significant result is not automatically a meaningful one. Learn what a p-value does and does not say, why large studies can flag tiny effects, and what a…

A 25% lower risk can mean 1 percentage point or far more. Learn the difference between relative and absolute effects, how number needed to treat works, and what to ask w…

What a surrogate endpoint is, how it differs from outcomes patients feel or live with, and why a lab or scan change alone does not show a treatment helps.

Why exciting early results often do not hold up: small studies, chance, differences between models and people, and the high failure rate of drug candidates in human tria…

How press releases and news stories exaggerate health research, what studies found about spin, and simple questions to ask before believing a headline about new science.

What a Cochrane review found about industry-sponsored studies and favorable results, what funding does and does not prove, and how to read disclosures in health research.

What systematic reviews and meta-analyses are, how they pool studies, what they can and cannot fix, and how to judge whether a review is trustworthy.

What observational studies can and cannot show, how confounding creates false links between a habit or product and health, and the Women's Health Initiative as a worked …

A plain-language definition of the microbiome, where it lives on the body, how many microbes there are, how it changes, and how scientists study it, with limits on what …

What microbial diversity means, what large studies link it to, and why a higher or lower diversity number is not a reliable measure of anyone's health on its own.

Why finding a microbe linked to a disease does not show it causes the disease, with the main pitfalls in microbiome studies and a checklist for reading headlines.

Why scientists have not defined a single healthy microbiome, what is known about normal variation between people, and how to treat claims about an ideal gut profile.

An overview of what gut microbiome research has established, what it links to health, which microbiome-based medicines are approved, and what is still unproven.

What research shows about microbes on the skin, their link with eczema and acne, what trials of probiotics found, and why "microbiome-friendly" skincare claims need caut…

What research shows about the community of microbes in the mouth, from gum disease to heart and brain links, with association separated from proof and evidence labels on…

What research shows about the bacteria of the vagina, community types, bacterial vaginosis, pregnancy and HPV links, and the experimental status of live-bacteria treatme…

What the gut-brain axis is, how gut microbes may signal to the brain, which findings come from animals and which from people, and why probiotic mental-health trials rema…

How gut microbes and the immune system influence each other, what trials of microbiota-based therapies in autoimmune disease and cancer show, and why immune markers do n…

A claim-by-claim check of the gut-skin axis for eczema, acne and psoriasis, separating gut microbiome associations from trial results of probiotics and from marketing pr…

What short-chain fatty acids such as butyrate are, how gut microbes make them from fiber, and how much human evidence there is beyond animal and laboratory studies.

What controlled studies show about how fiber, fermented foods and whole diets change gut microbes, and why a change in microbes is not the same as a health benefit.

A plain overview of research on defined microbial products, including next-generation probiotics and bacterial consortia, and how far each has progressed in people.

Which fecal microbiota products the US FDA lists as approved, the C. difficile evidence behind them, how far other uses have got, and the safety record.

What the US FDA means by a live biotherapeutic product, how it differs from a probiotic supplement, and which examples are approved or still in trials.

What bacteriophage (phage) therapy is, what randomized trials and case series have found so far, and why it remains investigational rather than a routine treatment.

An overview of medicines that aim at the microbiome, from the two FDA-approved products to investigational consortia, phages and fecal transplant uses.

What "dysbiosis" means in microbiome research, why scientists argue about the word, and how to read it when a test report or product page says your gut is "out of balanc…

What consumer gut microbiome stool tests measure, what studies say about their accuracy and usefulness, and how they differ from stool tests doctors order for specific c…

A claim check on "personalized probiotics" chosen from a microbiome test: what the research does show about individual responses, and what has not been shown.

What microbiome scores, diversity numbers and gut health indexes are, how research versions are built, and why a single number on a test report is not a validated measur…

What studies of gut microbes, probiotics, "psychobiotics" and fecal transplants show about depression and anxiety, what they do not show, and why it is not a replacement…

Why finding a microbe or microbial marker linked to a condition does not make it something you can treat, and the steps research needs before a link becomes a treatment …

A plain-language definition of precision nutrition, how it differs from personalized and general nutrition advice, what inputs it uses, and what the evidence shows so fa…

How population-level dietary guidance and personalized nutrition advice differ, what trials comparing them show, and why neither is a universal winner.

What studies show about why people respond differently to the same food or diet, what "responders" and "non-responders" mean, and why variation alone does not prove a pe…

Explains the difference between a model that predicts a body response to food and a trial that shows people are healthier for following its advice, using real personaliz…

Why food diaries, recalls and questionnaires contain measurement error, what validation studies found, and why that matters for any personalized nutrition model built on…

What nutrigenetics research shows about using a person's DNA to guide food advice, including gene-diet studies, trials of genotype-based advice, and the limits of consum…

Whether gut microbiome measurements can guide food choices: what the main studies found, where they disagree, and why a stool report is not a diet prescription.

What blood tests can and cannot tell you about nutrition, including how inflammation and lab differences affect nutrient markers, and what trials of biomarker-based advi…

How continuous glucose monitor data is used as an input for nutrition research and apps, what the FDA clearance covers, and what the evidence does and does not show for …

What studies of personalized blood sugar prediction found, including the Israeli, UK and US cohorts and the trials built on them, and where the evidence stops.

What research says about meal suggestions from algorithms and AI chatbots: the trial-tested glucose models, the studies of chatbot meal plans, and why professional overs…

What evidence exists for tailoring vitamin, mineral and other nutrient advice to an individual, and why ordinary guidance and clinician review remain the starting point.

What "personalized" supplement packs claim, what trials of personalized nutrition and supplements actually show, and what to ask before trusting a custom bundle.

How to read accuracy claims for personalized nutrition and health prediction models, why testing on new people matters, and what published glucose-response models showed.

What randomized trials of personalized nutrition measured, how long they lasted, where they beat general advice, where they did not, and what is still unknown.

Whether personalized nutrition and health programs are worth the money, time and effort, based on economic reviews and trial results, with no prices quoted.

How company funding and ownership ties show up in personalized nutrition and testing research, what studies say about sponsorship and results, and how to read disclosure…

Why cutting foods out because of a food-sensitivity panel, gene report, microbiome result or glucose spike can backfire, with the evidence, who is most at risk and safer…

A plain-language guide to what genes are, what a gene variant is, and what "gene expression" means, with the limits that matter when reading health claims.

What genomics is, how it differs from genetics, what genome sequencing and GWAS studies do, and what genomic findings can and cannot tell you about health.

What epigenetics is, how DNA methylation and histone changes work, what human studies show about environment and inheritance, and what the word does not mean.

What transcriptomics, proteomics and metabolomics measure, how they differ from DNA testing, and why a molecular signal is not the same as a health outcome.

What multi-omics means, why researchers combine genome, RNA, protein and metabolite data, and why the approach is a research method, not a proven wellness test.

How genetic differences can affect response to some medicines, what the US FDA tables say, what two large trials found, and why this is not medicine advice.

What a polygenic risk score is, what it can predict, why it works less well outside European-ancestry groups, and why it is not a diagnosis or a plan.

How genetic risk prediction works, what single-gene and polygenic scores can and cannot say, how well they perform, and why a risk report is not a diagnosis.

How biomarkers are found and tested, the stages from discovery to clinical use, why most never reach patients, and how regulators define and qualify them.

How genes can affect response to medicines, which gene-drug links the FDA lists, what trials show for pharmacogenetic-guided care, and limits for consumer tests.

What studies show about links between smoking, body weight, diet and DNA methylation, why association is not causation, and what these findings do not mean for health ad…

What direct-to-consumer genetic tests can and cannot tell you, which specific tests the FDA has authorized as read, and the accuracy, privacy and insurance limits to kno…

Why running raw DNA data through third-party analysis services can produce spurious results, what evidence shows about false positives, and the privacy and regulatory ga…

What consumer epigenetic and methylation tests measure, how reliable the numbers are, how the FDA treats wellness tests, and where to read about aging clocks.

What multi-omics wellness packages bundle, what research profiling studies actually showed, how they are regulated in the US, and why outcome evidence for healthy buyers…

Why many genetic findings, especially polygenic scores and variant classifications, were built mostly on European-ancestry data and may be less accurate or less informat…

What a variant of uncertain significance (VUS) means on a genetic test report, how labs classify variants, how often VUS are later reclassified, and what a VUS does not …

Why a genetic result from a consumer test or raw data file can be wrong, what studies found about false positives for rare variants, and why clinical confirmation matter…

How genetic data can be identifying, what US, EU and UK rules say about it, what the US GINA law does and does not cover, and what incidental or secondary findings are.

Why claims about turning genes on or off, activating good genes or silencing bad ones, simplify how gene expression works, and how to read gene-expression findings in st…

Regenerative medicine aims to repair or replace damaged cells, tissues or organs. This page separates the few approved products from the many unproven claims, with sourc…

Plain-language guide to embryonic, adult (somatic) and induced pluripotent stem cells: what each can do, how iPS cells were discovered, and what is and is not proven in …

How stem cells specialize (differentiation), why the human body repairs more often than it regenerates, and how repair differs from replacing tissue, with approved examp…

Blood and bone marrow stem-cell transplants are established medical care for certain cancers and blood disorders. This page explains what they are, their risks, and why …

What mesenchymal stromal cells (often called MSCs or "mesenchymal stem cells") are, the one approved use, and what trials in knee arthritis, COVID-19 and kidney injury s…

Autologous cells come from you; allogeneic cells come from a donor. This page explains the difference, the trade-offs, approved examples and why "from your own body" is …

How a regulated cell-therapy clinical trial differs from a commercial "stem cell treatment" offered for a fee, with FDA and EMA warning signs and what studies of clinic …

What extracellular vesicles and exosomes are, why the words are used loosely, what trials exist, and why no exosome product is FDA-approved in the United States.

What "secretome" means, what studies on stem-cell secretome in skin, hair and nerve conditions can and cannot show, and how to read cell-free regeneration claims.

How laboratory studies identify and measure exosomes, how marketed exosome products differ, and what FDA warnings say about unapproved products.

Platelet-rich plasma (PRP) evidence condition by condition, from knee, ankle and tendon problems to hair loss and wounds, with trial results, mixed findings and US regul…

What tissue engineering, biomaterials and scaffolds are, which engineered products the FDA has approved for specific uses, and where the research is still early.

What organoids are, how researchers use them for disease models and drug testing, their known limits, and where they stand as a tool for patients and for transplant.

Where 3D bioprinting and bioengineered organ research stand, what a first human bioprinted-implant trial showed, and why printed or grown replacement organs are not clin…

What regulators and published reports say about infection, immune reactions, tumors and other unwanted tissue effects after stem cell and other cell-based products, and …

How contamination and manufacturing failures were found in cell and cord-derived products, and what published reports say about risks that depend on where in the body a …

What US, EU, UK and Canadian regulators and the stem cell research community say about clinics selling unapproved cell treatments, the warning signs they describe, and w…

What "stem cell" on a skincare label can mean, how the FDA separates cosmetics from drugs by claims, and what published research does and does not show for plant stem ce…

How the FDA, EMA, MHRA and Health Canada classify cell and tissue products, with named examples of approved products and indications, what RMAT and HCT/P mean, and what …

What gene therapy and gene addition are, how genes are delivered, which products the FDA has approved, and the serious risks and limits that come with them.

What gene editing and CRISPR are in plain language, the one approved CRISPR medicine and its evidence, the risks of unintended edits, and why germline editing is differe…

A plain-language overview of base editing and prime editing, how they differ from CRISPR cutting, the very early human evidence, and the open safety questions.

How RNA interference works, how siRNA medicines such as patisiran and inclisiran were tested and approved, what they were shown to do, and where the limits are.

What antisense oligonucleotides are, how nusinersen and tofersen were tested and approved, the difference between a biomarker and a clinical benefit, and the risks.

What mRNA medicines beyond vaccines are, what a randomized melanoma trial of an individualized mRNA cancer therapy found, and why most uses remain investigational.

What viral vectors are, which virus families carry gene therapies, what trials and FDA labels show about benefits and risks, and why a vector is not the same as a treatm…

How lipid nanoparticles and other non-viral carriers deliver RNA and gene-editing tools, what is approved or only investigational, and where delivery still falls short.

How gene and RNA medicines are steered to the right tissue, with examples from FDA labels of local delivery, liver-targeting tags and cell-based approaches, plus the bar…

How the immune system reacts to viral vectors and lipid carriers, what FDA labels say about antibody screening, liver and muscle inflammation, and why immune reactions l…

US FDA-listed gene therapies and RNA-based medicines by product, indication and approval date, with plain notes on what approval does and does not mean.

What investigational means for gene and RNA therapies, with worked examples from published early trials, what a registry record can and cannot show, and the warning sign…

What published trials and FDA records show for gene therapies in rare inherited diseases such as spinal muscular atrophy, inherited retinal disease and hemophilia B, and…

Context on CAR T-cell therapy and other gene-based cancer treatments: what they are, which are FDA-approved for which cancers, known side effects and what remains unprov…

What off-target edits, vector integration and delayed adverse events mean for gene therapy and gene editing, and how regulators and trials monitor patients for years aft…

The difference between somatic gene therapy (not passed to children) and germline editing (heritable), the ethical debate, the 2018 case of gene-edited babies and what g…

Why approved gene therapies can cost millions of dollars, what cost-effectiveness reviews and a US Medicaid access model say, and the practical barriers beyond price, wi…

A claim check on do-it-yourself and self-administered gene therapy: what the FDA says, why gene therapy needs medical oversight and what documented harms from gene thera…

What neuroplasticity means, what is well established, what is still debated (such as new neurons in adults), and why "boosting plasticity" claims need careful reading.

Plain-language differences between magnetic and electrical brain stimulation, from TMS and tDCS to ECT, vagus nerve stimulation and deep brain stimulation, with no winne…

Why a change in an EEG, brain scan or other brain signal is not the same as feeling or functioning better, with examples from brain stimulation research.

How transcranial magnetic stimulation is used in clinics, which U.S. devices the FDA has authorized for which uses, what trials show, and the safety limits.

What research shows for transcranial direct current stimulation (tDCS) and alternating current stimulation (tACS), including one FDA-approved depression product and why …

How implanted and noninvasive vagus nerve stimulation differ, which U.S. devices have regulator records for epilepsy, depression, stroke rehabilitation and headache, and…

What cranial electrical stimulation is, what trials show for anxiety, insomnia, depression and pain, and what the FDA's 2019 order about this device type does and does n…

Focused ultrasound for the brain covers different technologies, from an FDA-approved tremor procedure to early trials of blood-brain barrier opening, and this page keeps…

Neurofeedback trains people to change a brain-activity signal shown on a screen. This page reviews what controlled trials found for ADHD, pain and sleep, and what the FD…

Brain stimulation techniques for depression compared one by one, from ECT and TMS to implanted and home devices, with the evidence level and FDA status read for each.

Device-by-device look at neuromodulation for migraine, cluster headache and chronic pain, with the exact FDA indications read for each device and the trial evidence behi…

How vagus nerve, magnetic and direct-current stimulation have been tested to support stroke rehabilitation, with the one FDA-approved system, the trial results and the n…

What research shows about brain stimulation and memory or thinking, in healthy adults and in people with cognitive decline. Findings are mixed, small and tied to specifi…

FDA clearance and approval for brain stimulation belong to one named device and one stated use. Here is how to read them, with real examples and what they do not mean.

Clinic brain stimulation and consumer headsets differ in who screens you, how they are regulated and what has been tested. A plain comparison with one home example.

Seizure is the most serious theoretical risk of brain stimulation. This page covers urgent steps first, then who is usually excluded, metal and skin concerns, and what i…

Brain stimulation for depression is a medical topic with specific approvals and exclusions. Learn what home-use claims can and cannot mean, and why mood-disorder history…

Home-built or self-directed brain stimulation carries burn, mood and unpredictability risks that trial participants are protected from. This page explains why, with no i…

What photobiomodulation is, how it is proposed to work, where human trials and guidelines exist, where they do not, and how it differs from wellness-device marketing.

A condition-by-condition table of what systematic reviews and trials show for red and near-infrared light, with evidence labels, limits and what is not established.

What systematic reviews and guidelines show for bright-light therapy in seasonal and non-seasonal depression, bipolar depression and prevention, with safety limits and n…

Why wavelength, irradiance, fluence and timing are separate research variables, why trial results cannot be transferred between devices, and how to read dose reporting.

How to separate a specific light device's evidence and regulatory status from the field's general evidence, with U.S. examples of device categories, indications and what…

What pulsed electromagnetic field (PEMF) therapy is, its U.S. regulatory status for bone healing and postoperative pain, and what reviews show for osteoarthritis, back p…

Therapeutic ultrasound in physical therapy is not the ultrasound used for imaging; here is how it is regulated and what reviews show for knee, wrist, fracture and back p…

Extracorporeal shockwave therapy for heel, shoulder, tendon, knee and erectile problems: what the FDA approved, what Cochrane and other reviews show by condition, and th…

TENS, ultrasound, interferential current and other physical therapy devices: what Cochrane reviews and NICE guidance say, and where exercise-based care fits instead.

What hyperbaric oxygen therapy is used for in medicine, what trials and Cochrane reviews show for each use, and the risks, kept apart from wellness marketing.

A claim-by-claim check of hyperbaric oxygen marketed for anti-aging, athletic recovery, concussion and autism, separating blood or tissue markers from health outcomes.

What we could and could not find on breathing extra oxygen when you are healthy, how medical oxygen differs from oxygen bars, and why more oxygen is not automatically be…

What research on molecular hydrogen (hydrogen water and hydrogen gas) actually measured in people, which results were small, null or mixed, and why a plausible mechanism…

What U.S. federal regulation says about ozone, what reviews of medical ozone therapy found, and the case reports of heart and potassium problems after ozone blood treatm…

What is known about eye and skin risks from red light, LED masks, light boxes and laser-class devices, what clearance does and does not cover, and what is not known abou…

The physical risks of hyperbaric oxygen chambers: fire and burns, ear, sinus and lung pressure injury, oxygen-related seizures and temporary vision changes, with inciden…

What the FDA says about fire risk with hyperbaric oxygen devices, why home and soft-sided chambers raise extra concerns, and what clinical oversight and device clearance…

How to tell approved uses of hyperbaric oxygen, ozone, light devices and hydrogen from unapproved ones, with examples of claims that outpace evidence and what trials of …

What the body clock is, how light, food and other cues set it, what the 2017 Nobel Prize work showed, and what is and is not known about mistimed rhythms and health.

What research says about when people eat, from late-eating trials to time-restricted eating, with the evidence level, the limits and why no meal-timing plan is offered h…

What laboratory and clinical studies show about how light at different times of day affects the body clock, melatonin and sleep, and why this page gives no light schedul…

What studies find about night and rotating shift work, heart disease, cancer classification and shift work disorder, and how much of it is observational and uncertain.

What trials and reviews show about whether the time of day a medicine or treatment is given changes outcomes, including blood pressure and cancer immunotherapy. Not medi…

What WHO and the US EPA say about fine particles and other air pollutants, what the research links them to, how strong that evidence is, and the limits of personal fixes.

What research and agencies say about indoor air pollution and health, from cooking smoke and gas stoves to radon, and what is known about air cleaners, plants and ventil…

What WHO and systematic reviews say about environmental noise, sleep, heart disease and hearing, how strong the evidence is, and what is still uncertain.

What research shows about hot weather and health, from deaths and hospital visits to pregnancy outcomes, and what is and is not known about warnings and adaptation measu…

What research shows and does not show about endocrine-disrupting chemicals such as BPA and phthalates: animal versus human evidence, regulator positions and exposure-red…

What is known about microplastics and nanoplastics in the human body, what the first human studies found, why measurement is hard, and what regulators say about health r…

Plain summary of environmental exposures with strong agency-reviewed research, including lead, arsenic in water, radon and PFAS, and what is and is not known about each.

What toxicologists mean by exposure, absorbed dose and internal dose, why contact with a substance is not the same as the amount that enters the body, and how to read he…

The difference between a hazard (what a substance can do) and a risk (the chance of harm at a real level of contact), with plain examples and what official agencies mean…

Why finding a chemical in blood, urine or tissue shows contact, not necessarily harm, what biomonitoring can and cannot tell you, and how to read a lab result calmly.

What official guidance suggests for lowering contact with lead, PFAS, indoor air pollutants and plastics, what is known about whether it helps, and what has little evide…

What home and mail-in toxin, heavy metal, hair and urine tests can and cannot show, why results are easily misread, and what clinical and environmental testing is used f…

What the evidence and regulators say about detox, cleanse and chelation products: no proof they remove toxins, risks of unapproved products, and when chelation is a real…

A plain-language guide to the two arms of the immune system, how they work together, and why a lab measurement of either arm does not tell you how well someone is protec…

What inflammation is, how short-term inflammation differs from long-lasting inflammation, what tests like CRP can and cannot show, and what trial evidence says about tre…

What cytokines are, the main families, how they carry messages between cells, and why cytokine storms, cytokine panels and anti-cytokine drugs need to be kept apart.

How the nervous system and immune system signal each other, from sickness behavior to the vagus nerve, with the human trial results so far and why stress-and-immunity cl…

What trained immunity (innate immune memory) means, the BCG vaccine evidence in children and adults, and why the idea does not support supplements or products sold to tr…

What researchers mean by neuroinflammation, what cell, animal, imaging and human-trial evidence shows, and why immune activity in the brain is not yet a proven treatment…

What specialized pro-resolving mediators are claimed to do, what human studies measured, why their measurement is disputed, and what the evidence does not show about SPM…

What long COVID and related post-infectious conditions are, how they are defined, what trials have and have not shown, and why immune-marker findings are not proof of a …

A plain overview of targeted immunotherapies such as checkpoint inhibitors, monoclonal antibodies and biologics, what they are approved to do, their immune-related risks…

What trials and cohort studies show about eating patterns and inflammation markers such as CRP and IL-6, why markers are not outcomes, and what "anti-inflammatory diet" …

What "boost your immune system" claims say, why more immune activity is not the same as better protection, and what trials of common immune-support products show.

Why "reduces inflammation" is not the same as better health, with trial evidence that lowering inflammation markers helped in one trial, failed in another and raised inf…

Why a single blood marker such as CRP, an antibody level or a cell count cannot describe overall immune health, and what each one can and cannot show.

How to read headlines about changed immune cells, cytokines or antibodies, and why a lab change is not proof of fewer infections or better health, with trial examples.

What immune panels are, how clinicians use immunoglobulin and cell tests for suspected immune disease, and why a bundled panel sold as an immune-health score is not a va…

How a general wellness app differs from a prescription digital therapy, using FDA's own categories, two cleared insomnia products as examples, and what app store claims …

What clinical decision support software is, which tools the FDA treats as devices and which it does not, and what trials show about its effect on care and on patient out…

What trials and reviews show about artificial intelligence used to help diagnose disease, including FDA-listed devices, a Swedish mammography trial, and the gaps in real…

What research shows about people using AI chatbots for medical advice, why strong test scores did not carry over to real users, and the risks, with FDA and WHO statement…

What remote patient monitoring is, what trials show for heart failure and high blood pressure, how Medicare describes and oversees it, and where it falls short.

What research shows about CBT for insomnia delivered by app or website, how it compares with a therapist, the two cleared products, and who should check with a clinician…

What randomized trials show about mental health apps and digital programs for depression and anxiety, why results differ between products, and what one cleared prescript…

What trials show about diabetes apps and digital symptom monitoring for chronic illness, where clinician feedback matters, and why many people stop using these tools.

What symptom diaries, symptom-reporting programs and online symptom checkers have been tested for, where they help, where accuracy audits found gaps, and how to use a di…

Why a trial of one digital health product cannot be applied to other apps, what to check in an app trial, and how a sham-controlled study of a cleared product was design…

How health software and AI tools are checked before and after release, why strong test results can fall short in hospitals and clinics, and one widely used model that di…

Why opens, streaks and minutes in an app are not health results, what research shows about real-world app use and dropout, and which outcomes to look for instead.

Why AI chatbots can state wrong health information with confidence, what studies measured, and how automation bias leads people and clinicians to trust a wrong answer.

What studies of symptom checkers, health chatbots and device readings show about missed emergencies and false reassurance, and why symptoms should outrank a screen.

Which privacy laws cover health apps and which do not, what the US FTC alleged in four app cases, what a 2019 study found about app data sharing, and what to check.

How health algorithms and devices have performed unequally across race, sex, skin tone and income, with named studies and FDA statements on pulse oximeters.

How regulators in the US, EU, UK and Germany decide whether an app or AI tool is a medical device, with named FDA examples and what authorization does and does not show.

What artificial intelligence adds to drug discovery, what early trial data show, and why an AI-designed molecule is a candidate to be tested, not a proven treatment.

How computer modeling, including molecular docking, is used in biology and drug research, and why a predicted fit between a molecule and a protein is not evidence of a h…

What AlphaFold and similar tools do, what they predict well, and why a predicted protein shape is a useful hypothesis rather than proof of how a drug or supplement works.

How automated high-throughput screening tests huge numbers of compounds in the lab, why many early hits do not hold up, and why a screening hit is not a treatment.

What organoids and organ-on-chip devices are, how they are used to test drugs, and why a result in a dish is not proof that a treatment works or is safe in people.

What single-cell sequencing and spatial transcriptomics measure, what they have added to research, and why cell maps and gene-activity patterns are not diagnoses or trea…

How adaptive and platform clinical trials change course using pre-set rules, what these designs can speed up, and what they do not change about the strength of evidence.

What regulators mean by real-world data and real-world evidence, how it differs from a randomized trial, and what a 32-trial comparison found about when the two agree.

What a digital biomarker from a sensor or wearable is, the three-part check (verification, analytical and clinical validation) that shows whether it measures something r…

What patient-reported outcomes and their questionnaires measure, why they matter for symptoms like pain and fatigue, how they are checked for quality and where they can …

How a medicine moves from a laboratory idea through animal studies, three phases of human trials, regulator review and post-market monitoring, and why most candidates ne…

What animal studies are for, why results in mice, rats or other animals often fail to carry over to people, and how to read a headline built on an animal study.

Why well-run trials assign people by chance, hide who gets what and use a placebo, what each step protects against and what meta-research shows when they are missing.

What an effect size and a 95 percent confidence interval tell you, how they differ from a p-value, how to spot relative versus absolute numbers and what common misreadin…

What analytical validity means, how labs and regulators think about whether a test measures what it says, and why a precise result is not the same as a useful one.

Clinical validity asks whether a test result relates to a disease; clinical utility asks whether using it improves care. Specific uses and limits, with real examples.

Plain-language definitions of sensitivity, specificity and predictive values, why a positive result can still be wrong, and how to read these numbers for a real test.

What a lab reference range is and is not, why healthy people fall outside it, and why repeat results vary because of the body, the sample and the method.

Why more testing can produce more false alarms, how repeated screening adds up, and what incidental findings on scans are, with real figures from published studies.

How screening differs from diagnostic testing, what overdiagnosis is, why screening statistics can mislead, and what published estimates show for breast, lung and prosta…

Why a test that predicts who is at higher risk is a different thing from a test that tells you which treatment will work, with examples from heart risk, circulating tumo…

A claim check on single "health", "biological age" or "longevity" scores built from many blood markers: what is hidden inside the number, what evidence to ask for, and c…

What multi-omics test panels measure, what research cohorts have and have not shown, how they are regulated in the US, and the questions to ask before relying on a bundl…

What blood-based liquid biopsy tests can and cannot do, test by test: approved treatment-matching tests, a blood test for colorectal screening, and research uses such as…

Where multi-cancer early-detection blood tests stand as of October 2026: the NHS-Galleri and PATHFINDER 2 results, the FDA advisory panel vote, and what is still unknown.

What common inflammation blood tests (CRP, hs-CRP, ESR) and cytokine panels can show, where they are used in medicine, and why a single number or bundled panel has limit…

What "established" and "investigational" mean for health products and procedures, how a medicine moves from testing to approval in the United States, and what a trial li…

Why approval is for a specific use, with a U.S. example of one active ingredient in two products, and how stem-cell, exosome and device approvals are narrower than marke…

What off-label use of an approved drug means in the United States, why prescribers do it, what is and is not known about safety and benefit, and questions to ask your pr…

A plain guide to joining a clinical trial in the United States: what consent must cover, what phases mean for you, your right to leave, and why a trial listing is not an…

How U.S. expanded access ("compassionate use") and the Right to Try Act work for people with serious illness, who must agree, what it costs, and why it is not a purchase…

What U.S. FDA has said about unapproved stem cell, exosome and other "regenerative" products sold by clinics, the harms reported, red flags in marketing, and how to repo…

What informed consent means, what U.S. research rules say a consent process must cover, and why a signed form for an emerging treatment does not show the treatment is ap…

Why the long-term effects of a new treatment are often not known at approval, how the FDA handles this for gene therapies, and one CAR T example of a risk found after ap…

How to report a bad reaction to an unapproved or emerging product to the FDA MedWatch program in the United States or the UK Yellow Card scheme, and what reporting can a…

What product quality means for cell, gene and exosome products, what U.S. rules and FDA reports say about contamination and identity, and the questions to ask before any…

What therapeutic misconception is (mistaking a research study for personal treatment), what studies show about how common it is, why it happens, and why hope is not the …

How money can shape research and clinic advice for emerging treatments, what U.S. rules require researchers to disclose, what the Cochrane review found about sponsorship…

What US, EU, Canadian and UK official sources say about traveling abroad for unproven treatments, what is known about complications, and which questions to ask first.

Which US, EU and genetic-data rules cover health data from apps, trackers, DNA tests and AI tools, where the gaps are, and what regulators have said and done.

A jurisdiction-by-jurisdiction overview of what US, Canadian and EU official sources say about genetic privacy and discrimination law, including what GINA does not cover.

Why children, pregnant people, seriously ill patients and others need extra care around emerging interventions, with what US research rules, the FDA and the EMA say.

What the FDA disclaimer on supplements means, why US regulators say disclaimers and words like promising or preliminary do not fix overstated health claims, and how to r…

A side-by-side look at personalized nutrition and general dietary advice: what each is, what trials have measured, where results differ, and what stays unproven.

Genetic tests read the DNA sequence; epigenetic tests read chemical marks on DNA. This page compares what each measures, how reliable they are, and what they cannot tell…

Probiotics, live biotherapeutic products and fecal microbiota medicines are not the same. This page compares what each is, what trials show, how they are regulated and t…

Stem cells are living cells; exosomes are tiny particles that cells release. This page compares what each is, the human evidence, US regulatory status and the risks of u…

Platelet-rich plasma is made from your own blood; cell-based products use stem or stromal cells. This page compares trial evidence for knee osteoarthritis, regulation an…

Gene therapy usually adds or replaces genetic material; gene editing changes DNA already in the cell. This page compares the two, with one approved example, risks and wh…

RNA therapies change how genes' instructions are used; gene therapies add or edit genetic material. This page compares them in plain language, with approved examples, ri…

How clinic-based brain stimulation such as TMS differs from consumer brain devices in regulation, evidence, supervision and safety, with no universal winner and no use i…

How hyperbaric oxygen in a pressurized chamber differs from ordinary supplemental oxygen in purpose, regulation, evidence and risk, with no universal winner and no treat…

How prescription digital therapeutics differ from general wellness apps in evidence, FDA oversight and claims, with no universal winner and no advice to use or drop any …

The difference between a biomarker, a surrogate endpoint and a clinical outcome, why a lab number can improve while health does not, and how to read claims, with no univ…

What "clinically proven" can and cannot mean when it rests on a single small study, why small trials overstate effects, and what better evidence looks like.

What "FDA registered" means, why it is not the same as FDA approved, cleared or authorized, and how to check a product through the FDA's own databases.

What a patent and "patent pending" do and do not mean for a health product, why neither shows that it works or is safe, and what evidence to look for instead.

A claim check on "natural means safer": what the claim says, what US government and clinical sources show about natural products and harm, and where the evidence stops.

A claim check on "personalized means better": what trials of personalized nutrition show, where personalization helped, where it did not, and what remains unproven.

A claim check on "changes gene expression" in wellness marketing: why a change in gene activity is not a treatment, what regulators allow on labels, and what evidence wo…

A claim check on "reduces inflammation means improves health": what trials show when an inflammation marker falls, with heart-disease and vitamin D examples and the limi…

A claim check on "detoxifies the body": what the liver and kidneys already do, what reviews found about detox diets and cleanses, and the safety problems some products h…

A claim check on "regenerates any tissue": what FDA says about unapproved regenerative products, documented harms, trial results for stem cell injections, and what is ac…

A claim check on "AI discovered it, so it must work": what an early analysis and one phase 2a trial show, why discovery method is not evidence of benefit, and what to lo…

The fixed template we use to summarize a study, what we always report, how publication dates differ from our update dates, and why we avoid the word "latest".

A plain guide to the kinds of sources behind health headlines, from press releases and conference abstracts to preprints, journal papers and regulatory decisions, and wh…

What corrections, expressions of concern and retractions are, why papers are retracted, how to check whether a study has one, and why a retraction does not settle a whol…

A field-by-field map of the kinds of evidence behind emerging wellness science, what question each field still has to answer, and where to read the detailed guide.

A step-by-step search routine for finding studies, trial registry records, retraction notices and regulatory records on an emerging health topic, and what each record ca…

Plain-language definitions of 18 research terms used across the Emerging Wellness Science library, from translational research and biomarkers to absolute risk and regula…